S.-J. Wu

发表

The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia

B. Ko, K. Kuo, M. Yao, 2011, Leukemia.

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

B. Ko, M. Yao, Yuan-Yeh Kuo, 2014, Blood Cancer Journal.

A New Route to Enhance the Light‐Harvesting Capability of Ruthenium Complexes for Dye‐Sensitized Solar Cells

K. Ho, S.-J. Wu, C.‐Y. Chen, 2007 .

Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients

B. Ko, M. Yao, Yao-chang Chen, 2009, Leukemia.

Genetic alterations and their clinical implications in older patients with acute myeloid leukemia

B. Ko, M. Yao, Yuan-Yeh Kuo, 2016, Leukemia.

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

B. Ko, C. Li, M. Yao, 2015, Blood Cancer Journal.

Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations

M. Yao, Chien-Yuan Chen, W. Tsay, 2007, Leukemia.

High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes

Chung-Wu Lin, B. Ko, M. Yao, 2011, British Journal of Cancer.

Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia

S-J Wu, B. Ko, M. Yao, 2014, Leukemia.